Earlier in December 2025, Recursion Pharmaceuticals reported positive Phase 1b/2 TUPELO trial data for REC-4881 in familial adenomatous polyposis, showing rapid and durable reductions in polyp burden ...
Recursion Pharmaceuticals (RXRX) added ~11% in the morning trading on Wednesday after J.P. Morgan upgraded the AI-driven biotech to Overweight from Neutral, citing a blockbuster sales potential for ...
Space and time aren’t just woven into the background fabric of the universe. To theoretical computer scientists, time and space (also known as memory) are the two fundamental resources of computation.
Recursion Pharmaceuticals, Inc. remains a Sell as pipeline progress, notably REC-4881 in FAP, fails to surpass cheap alternatives like Celebrex. REC-4881's Phase 1/2 data show a median polyp reduction ...
Dec 8 (Reuters) - Recursion Pharma (RXRX.O), opens new tab, which uses artificial intelligence to discover new drug candidates, said on Monday its experimental oral drug helped reduce abnormal growths ...
Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.71. LONDON — In the year-plus since Najat Khan joined the AI-focused drug ...
Dr. Shaw and Dr. Hilton teach software engineering at Carnegie Mellon University. For decades, computer science students have been taught a central skill: using computers to solve problems. In ...
The oldest and best-known preprint repository, arXiv, has announced that it will no longer accept review or position papers in computer science. The website will make exceptions only for papers that ...
Management believes it can drastically cut down the time and cost to bring drugs to market. The company is involved with multiple clinical trials, but none of them are in late stages just yet. Its ...
A prominent computer science professor at one of the world’s most prestigious universities says his graduates are struggling to find work — a far cry from just four years ago when they had their pick ...
Hosted on MSN
Where Will Recursion Pharmaceuticals Be in 5 Years?
Recursion Pharmaceuticals uses AI to expedite the laborious process of developing drugs. The company could benefit from industry-wide regulatory changes as well as its own clinical progress. However, ...
UC Berkeley professor Hany Farid says computer science students are struggling to find jobs. Farid said Berkeley grads used to have "the run of the place. That is not happening today." The advice ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results